116 related articles for article (PubMed ID: 17952216)
1. Cost of a dedicated ART clinic.
Harling G; Bekker LG; Wood R
S Afr Med J; 2007 Aug; 97(8):593-6. PubMed ID: 17952216
[TBL] [Abstract][Full Text] [Related]
2. Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe.
Chingombe I; Mapingure MP; Balachandra S; Chipango TN; Gambanga F; Mushavi A; Apollo T; Suraratdecha C; Rogers JH; Ruangtragool L; Gonese E; Musuka GN; Mugurungi OM; Harris TG
PLoS One; 2021; 16(8):e0256291. PubMed ID: 34407129
[TBL] [Abstract][Full Text] [Related]
3. The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients.
Harling G; Wood R
J Acquir Immune Defic Syndr; 2007 Jul; 45(3):348-54. PubMed ID: 17496562
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
[TBL] [Abstract][Full Text] [Related]
6. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
[TBL] [Abstract][Full Text] [Related]
7. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
[TBL] [Abstract][Full Text] [Related]
8. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.
Marseille E; Giganti MJ; Mwango A; Chisembele-Taylor A; Mulenga L; Over M; Kahn JG; Stringer JS
PLoS One; 2012; 7(12):e51993. PubMed ID: 23284843
[TBL] [Abstract][Full Text] [Related]
9. A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa.
Leisegang R; Maartens G; Hislop M; Sargent J; Darkoh E; Cleary S
PLoS One; 2013; 8(2):e53570. PubMed ID: 23405073
[TBL] [Abstract][Full Text] [Related]
10. Cost to patients of obtaining treatment for HIV/AIDS in South Africa.
Rosen S; Ketlhapile M; Sanne I; DeSilva MB
S Afr Med J; 2007 Jul; 97(7):524-9. PubMed ID: 17805455
[TBL] [Abstract][Full Text] [Related]
11. Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.
Pillai N; Foster N; Hanifa Y; Ndlovu N; Fielding K; Churchyard G; Chihota V; Grant AD; Vassall A
PLoS One; 2019; 14(2):e0210622. PubMed ID: 30742623
[TBL] [Abstract][Full Text] [Related]
12. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.
Meyer-Rath G; Miners A; Santos AC; Variava E; Venter WD
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e25-32. PubMed ID: 22895437
[TBL] [Abstract][Full Text] [Related]
13. Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa.
Martinson N; Mohapi L; Bakos D; Gray GE; McIntyre JA; Holmes CB
J Acquir Immune Defic Syndr; 2009 Mar; 50(3):327-30. PubMed ID: 19194308
[TBL] [Abstract][Full Text] [Related]
14. The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case.
Meyer-Rath G; van Rensburg C; Chiu C; Leuner R; Jamieson L; Cohen S
PLoS One; 2019; 14(2):e0210497. PubMed ID: 30807573
[TBL] [Abstract][Full Text] [Related]
15. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.
Cianci F; Sweeney S; Konate I; Nagot N; Low A; Mayaud P; Vickerman P
PLoS One; 2014; 9(6):e100107. PubMed ID: 24950185
[TBL] [Abstract][Full Text] [Related]
16. HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.
Meyer-Rath G; Over M
PLoS Med; 2012; 9(7):e1001247. PubMed ID: 22802731
[TBL] [Abstract][Full Text] [Related]
17. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.
Long LC; Maskew M; Brennan AT; Mongwenyana C; Nyoni C; Malete G; Sanne I; Fox MP; Rosen S
AIDS; 2017 Jul; 31(11):1611-1619. PubMed ID: 28463879
[TBL] [Abstract][Full Text] [Related]
18. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa.
Rosen S; Long L; Sanne I
Trop Med Int Health; 2008 Aug; 13(8):1005-15. PubMed ID: 18631314
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness and cost-effectiveness of community-based support for adolescents receiving antiretroviral treatment: an operational research study in South Africa.
Fatti G; Jackson D; Goga AE; Shaikh N; Eley B; Nachega JB; Grimwood A
J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485714
[TBL] [Abstract][Full Text] [Related]
20. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs.
Keiser P; Nassar N; Kvanli MB; Turner D; Smith JW; Skiest D
J Acquir Immune Defic Syndr; 2001 May; 27(1):14-9. PubMed ID: 11404515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
